Literature DB >> 9820179

Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro.

R Jung1, W Krüger, S Hosch, M Holweg, N Kröger, K Gutensohn, C Wagener, M Neumaier, A R Zander.   

Abstract

Several reverse transcriptase polymerase chain reaction (RT-PCR) assays have been described for the detection of circulating tumour cells in blood and bone marrow. Target mRNA sequences for this purpose are the cytokeratins (CK) 19 and 20, the carcinoembryonic antigen (CEA), and the prostate-specific antigen messages. In this study, we investigated biological factors influencing the specificity of the CK19 and CEA RT-PCR assays. Bone marrow, granulocyte colony-stimulating factor (G-CSF)-mobilized blood stem cells and peripheral blood samples obtained from healthy volunteers (n = 15; CEA n = 7), from patients with epithelial (n = 29) and haematological (n = 23) cancer and from patients with chronic inflammatory diseases (n = 16) were examined. Neither CEA nor cytokeratin 19 messages could be amplified from bone marrow samples from healthy subjects and from patients with haematological malignancies. In contrast, specimens from patients with inflammatory diseases scored positive up to 60%. To investigate the influence of inflammation on target mRNA expression, haemopoietic cells were cultured with and without cytokine stimulation in vitro. CK19 messages could be easily detected in cultured marrow cells without further stimulation, CEA messages only after gamma-interferon (gamma-INF) stimulation. In contrast, G-CSF-mobilized peripheral blood stem cells were positive for CK19 messages only after stem cell factor (SCF) or interleukin stimulation. We conclude that transcription of so-called tissue-specific genes is inductible in haemopoietic tissues under certain conditions. These factors have to be considered in future applications of RT-PCR for the detection of minimal residual disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820179      PMCID: PMC2063007          DOI: 10.1038/bjc.1998.653

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction.

Authors:  S T Traweek; J Liu; H Battifora
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

2.  Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

Authors:  G Schlimok; I Funke; B Holzmann; G Göttlinger; G Schmidt; H Häuser; S Swierkot; H H Warnecke; B Schneider; H Koprowski; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients.

Authors:  W Krüger; C Krzizanowski; M Holweg; M Stockschläder; N Kröger; R Jung; K Mross; W Jonat; A R Zander
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction.

Authors:  R Jung; P Ahmad-Nejad; M Wimmer; M Gerhard; C Wagener; M Neumaier
Journal:  Eur J Clin Chem Clin Biochem       Date:  1997-01

6.  Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.

Authors:  B Smith; P Selby; J Southgate; K Pittman; C Bradley; G E Blair
Journal:  Lancet       Date:  1991-11-16       Impact factor: 79.321

7.  [Second International Expert Meeting of the German Foundation for Cancer Research, "Current trends in cancer research." Critical review of tumour markers in diagnosis and surveillance].

Authors:  S von Kleist; C Wagener; H Breuer
Journal:  Onkologie       Date:  1980-12

8.  Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon.

Authors:  H Takahashi; Y Okai; R J Paxton; L J Hefta; J E Shively
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

Review 9.  Cytokine mediators of septic infections in the normal and granulocytopenic host.

Authors:  A Waage; S Steinshamn
Journal:  Eur J Haematol       Date:  1993-05       Impact factor: 2.997

10.  The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.

Authors:  S Noguchi; T Aihara; S Nakamori; K Motomura; H Inaji; S Imaoka; H Koyama
Journal:  Cancer       Date:  1994-09-01       Impact factor: 6.860

View more
  23 in total

1.  Bromodeoxyuridine increases keratin 19 protein expression at a posttranscriptional level in two human lung tumor cell lines.

Authors:  P Meleady; M Clynes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

2.  Systemic inflammation as a confounding factor in cancer biomarker discovery and validation.

Authors:  Magdalena Chechlinska; Magdalena Kowalewska; Radoslawa Nowak
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

3.  Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer.

Authors:  Peilin Huang; Jingmei Wang; Ying Guo; Wei Xie
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-18       Impact factor: 4.553

4.  Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.

Authors:  F A Vlems; J H S Diepstra; I M H A Cornelissen; T J M Ruers; M J L Ligtenberg; C J A Punt; J H J M van Krieken; Th Wobbes; G N P van Muijen
Journal:  Mol Pathol       Date:  2002-06

5.  Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.

Authors:  Dalibor Antolovic; Luis Galindo; Anina Carstens; Nuh Rahbari; Markus W Büchler; Jürgen Weitz; Moritz Koch
Journal:  BMC Biotechnol       Date:  2010-04-28       Impact factor: 2.563

6.  Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?

Authors:  Michael Conzelmann; Ulrich Linnemann; Martin R Berger
Journal:  Int J Colorectal Dis       Date:  2004-09-30       Impact factor: 2.571

Review 7.  Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.

Authors:  Zacharoula Panteleakou; Peter Lembessis; Antigone Sourla; Nikolaos Pissimissis; Aristides Polyzos; Charalambos Deliveliotis; Michael Koutsilieris
Journal:  Mol Med       Date:  2008-12-03       Impact factor: 6.354

8.  Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.

Authors:  Alison L Allan; Michael Keeney
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

9.  Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.

Authors:  I Van der Auwera; D Peeters; I H Benoy; H J Elst; S J Van Laere; A Prové; H Maes; P Huget; P van Dam; P B Vermeulen; L Y Dirix
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

10.  Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection.

Authors:  Lili Wang; Yanyan Wang; Yajing Liu; Min Cheng; Xu Wu; Haiming Wei
Journal:  J Exp Clin Cancer Res       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.